Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO for Chemotherapy-Induced Thrombocytopenia in Sarcoma
NCT00283582Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2001
- Primary completion
- Nov 2004
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of recombinant human thrombopoietin in Thrombocytopenia, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2001; status: completed.
02
Drugs
recombinant human thrombopoietin
03
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT00283582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00283582.